Enanta Pharmaceuticals, Inc. (ENTA)
13.54
-0.20
(-1.46%)
USD |
NASDAQ |
Mar 06, 16:00
13.53
-0.01
(-0.07%)
After-Hours: 20:00
Enanta Pharmaceuticals SG&A Expense (TTM) : 40.10M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Agios Pharmaceuticals, Inc. | 180.28M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| Savara, Inc. | 37.38M |
| BioMarin Pharmaceutical, Inc. | 1.153B |